Animal Vaccines Market Size Projected to Reach USD 36.46 Billion by 2034 | CAGR: 9.7%

BySheetal Gajbhiye

The global animal vaccines market was valued at USD 14.51 billion in 2024 , and it is projected to grow from USD 15.85 billion in 2025 to USD 36.46 billion by 2034 , exhibiting a compound annual growth rate (CAGR) of 9.7% during the forecast period (2025–2034) . This substantial growth is primarily driven by increasing demand for livestock-derived products, rising pet ownership, growing awareness about zoonotic diseases, and advancements in vaccine technologies.

Market Definition

Animal Vaccines : Biological preparations used to stimulate immunity against infectious diseases in both livestock identification and companion animals. These vaccines play a critical role in disease prevention, ensuring animal health and welfare, enhancing productivity in agriculture, and reducing the risk of zoonotic disease transmission to humans.

Key Report Highlights

  • The livestock segment holds the largest share of the animal vaccines market due to the high demand for vaccines that prevent diseases in farm animals such as cattle, swine, and poultry, which are essential for food production.
  • The companion animal segment is registering the fastest growth , driven by rising pet adoption rates and increased awareness regarding preventive healthcare for pets.
  • Attenuated live vaccines dominate the market due to their ability to provide long-lasting immunity with fewer doses , while the recombinant vaccines segment is growing rapidly, fueled by biotechnological innovations and the development of safer, more targeted formulations.
  • Subcutaneous vaccines hold the largest market share due to their ease of administration and widespread use in veterinary practices , whereas the intranasal route is experiencing the fastest growth due to its non-invasive nature and effectiveness in preventing respiratory infections .
  • The hospital/clinic pharmacy segment remains the dominant distribution channel, owing to the involvement of veterinary professionals in vaccine administration. Meanwhile, the e-commerce segment is witnessing the fastest growth , supported by the rise in online sales platforms and home delivery services for pet care products.

Market Overview: Key Figures at a Glance

  • Market Value in 2024 : USD 14.51 billion
  • Projected Market Size in 2025 : USD 15.85 billion
  • Projected Market Size in 2034 : USD 36.46 billion
  • Anticipated CAGR (2025–2034) : 9.7% 

Get access to the full report or request a complimentary sample for in-depth analysis:  https://www.polarismarketresearch.com/industry-analysis/animal-vaccines-market 

Market Growth Drivers

The growth of the animal vaccines market is being propelled forward by several key factors:

  • Rising prevalence of zoonotic and infectious animal diseases globally
  • Increasing demand for meat, dairy, and poultry products , necessitating healthy livestock management
  • Growing investment in veterinary healthcare infrastructure and government support for disease control programs
  • Technological advancements in molecular biology and recombinant DNA technology enabling the development of next-generation vaccines
  • Expansion of pet insurance coverage and rising disposable incomes driving higher spending on pet wellness

Market Key Players

The competitive landscape features a mix of established multinational corporations and emerging regional players focused on innovation, product diversification, and strategic partnerships. Notable participants include:

  • Zoetis Inc.
  • Merck & Co., Inc. (Merck Animal Health)
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
  • Virbac
  • Phibro Animal Health Corporation
  • HIPRA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Biogenesis Bago
  • Indian Immunologicals Limited
  • Neogen Corporation
  • IDT Biologika GmbH
  • Hester Biosciences Limited

Similar Posts